Last update :
18/06/2021
References   References 4545  
Type : Journal
Web link : 10.1272/jnms.JNMS.2022_89-104

Research teams : Tokyo - Nippon Medical School Hospital, Department of Pharmacy
Authors : Kondo M, Nagano M, Yoshida M, Yoshida N, Tagui N, Yoshida M, Sugaya K, Takase H.
Title : Physical compatibility of nafamostat with analgesics, sedatives, and muscle relaxants for coronavirus disease treatment.
Reference : Journal of Nippon Medical school 2021

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionDexmedetomidine Sympathomimetic
Compatible 4 µg/ml + InjectionNafamostat 10 mg/mL + Glucose 5%
InjectionFentanyl citrate Analgesic
Compatible 50 µg/ml + InjectionNafamostat 10 mg/mL + Glucose 5%
InjectionMidazolam hydrochloride Anxiolytic
Compatible 5 mg/ml + InjectionNafamostat 10 mg/mL + Glucose 5%
InjectionMorphine hydrochloride Analgesic
Compatible 2 mg/ml + InjectionNafamostat 10 mg/mL + Glucose 5%
InjectionNafamostat Anticoagulant
Compatible 10 mg/mL + InjectionDexmedetomidine 4 µg/ml + Glucose 5%
Compatible 10 mg/mL + InjectionFentanyl citrate 50 µg/ml + Glucose 5%
Compatible 10 mg/mL + InjectionMidazolam hydrochloride 5 mg/ml + Glucose 5%
Compatible 10 mg/mL + InjectionMorphine hydrochloride 2 mg/ml + Glucose 5%
Compatible 10 mg/mL + InjectionRocuronium bromide 10 mg/ml + Glucose 5%
InjectionRocuronium bromide Curarimimetic
Compatible 10 mg/ml + InjectionNafamostat 10 mg/mL + Glucose 5%

  Mentions Légales